Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

HIV · Hematologic Malignancies

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact National Cancer Institute Referral Office) · 888-624-1937

Study leads

Mustafa A Hyder, M.D.
Principal Investigator
National Cancer Institute (NCI)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Atlanta, United States

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Human Papilloma Virus · Anal Dysplasia · HIV

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States · Baltimore, United States

Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)

Hiv · Cryptococcal Meningitis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Kampala, Uganda · Mbarara, Uganda

Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics

Sexual Risk Behavior for HIV-infection · Reproductive Health

Abroad (travel likely)Recruiting

New Haven, United States